scholarly article | Q13442814 |
P50 | author | Marcela F. Pasetti | Q56380831 |
Myron M. Levine | Q29564379 | ||
P2093 | author name string | Haim Levy | |
William C Blackwelder | |||
James E Galen | |||
Jin Yuan Wang | |||
Magaly Chinchilla | |||
Jeffrey E Vogel | |||
Christopher Vindurampulle | |||
P2860 | cites work | Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. | Q50463859 |
Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. | Q54435126 | ||
Recombinant DNA Risk Assessment Studies in Humans: Efficacy of Poorly Mobilizable Plasmids in Biologic Containment | Q54490568 | ||
Plasmids from freshwater environments capable of IncQ retrotransfer are diverse and include pQKH54, a new IncP-1 subgroup archetype. | Q54584426 | ||
Use of the Escherichia coli SSB gene to prevent bioreactor takeover by plasmidless cells. | Q54721080 | ||
Selective pressure affects transfer and establishment of a Lactobacillus plantarum resistance plasmid in the gastrointestinal environment | Q57284096 | ||
EspB and EspD require a specific chaperone for proper secretion from enteropathogenicEscherichia coli | Q59307488 | ||
Survival and transfer in the human gut of poorly mobilizable (pBR322) and of transferable plasmids from the same carrier E. coli | Q70182006 | ||
Transfer of plasmid and chromosomal glycopeptide resistance determinants occurs more readily in the digestive tract of mice than in vitro and exconjugants can persist stably in vivo in the absence of glycopeptide selection | Q79730636 | ||
Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T | Q22065494 | ||
Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria | Q22121986 | ||
Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18 | Q24554266 | ||
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
Human intestinal bacteria as reservoirs for antibiotic resistance genes | Q28279671 | ||
Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine | Q28387065 | ||
Antibiotic-free plasmid stabilization by operator-repressor titration for vaccine delivery by using live Salmonella enterica Serovar typhimurium | Q33769332 | ||
Retrotransfer or gene capture: a feature of conjugative plasmids, with ecological and evolutionary significance | Q33812337 | ||
In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors | Q34003031 | ||
Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers | Q34003500 | ||
Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy | Q34025527 | ||
Shaping bacterial genomes with integrative and conjugative elements | Q34327965 | ||
Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system | Q35553394 | ||
Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis | Q35783791 | ||
Plasmid selection in Escherichia coli using an endogenous essential gene marker. | Q36856568 | ||
Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors | Q36898558 | ||
Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA. | Q37623663 | ||
Escherichia coli single-stranded DNA-binding protein: multiple DNA-binding modes and cooperativities | Q38312769 | ||
Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. | Q39146446 | ||
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. | Q39513282 | ||
Single-stranded DNA binding proteins required for DNA replication | Q39740421 | ||
Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization | Q40008502 | ||
Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors | Q40655503 | ||
Construction of genetically defined double aro mutants of Salmonella typhi | Q40743402 | ||
Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans | Q41886615 | ||
Effect of plasmid copy number and lac operator sequence on antibiotic-free plasmid selection by operator-repressor titration in Escherichia coli | Q45071360 | ||
Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens | Q45764942 | ||
Natural transfer of sulphonamide and ampicillin resistance between Escherichia coli residing in the human intestine | Q46289169 | ||
Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system | Q50079113 | ||
Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization | Q50103516 | ||
A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens | Q50134864 | ||
Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain | Q50181478 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Salmonella enterica | Q2264864 |
P304 | page(s) | 337-347 | |
P577 | publication date | 2009-11-02 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | A new generation of stable, nonantibiotic, low-copy-number plasmids improves immune responses to foreign antigens in Salmonella enterica serovar Typhi live vectors | |
P478 | volume | 78 |
Q39015820 | A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection |
Q27028105 | Antibiotic-free selection in biotherapeutics: now and forever |
Q34070619 | Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines |
Q37123743 | Characterization of intracellular growth regulator icgR by utilizing transcriptomics to identify mediators of pathogenesis in Shigella flexneri |
Q58759445 | Comparative evaluation of Salmonella Typhimurium vaccines derived from UK-1 and 14028S: Importance of inherent virulence |
Q34529634 | Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines |
Q53704376 | Conversion of RpoS- Attenuated Salmonella enterica Serovar Typhi Vaccine Strains to RpoS+ Improves Their Resistance to Host Defense Barriers. |
Q64055283 | Evaluating Shigella flexneri Pathogenesis in the Human Enteroid Model |
Q45349197 | IFNγ expression by an attenuated strain of Salmonella enterica serovar Typhimurium improves vaccine efficacy in susceptible TLR4-defective C3H/HeJ mice |
Q28972559 | Immunology of Gut Mucosal Vaccines |
Q40633254 | Improved delivery of the OVA-CD4 peptide to T helper cells by polymeric surface display on Salmonella |
Q30415132 | Intranasal vaccination in mice with an attenuated Salmonella enterica Serovar 908htr A expressing Cp15 of Cryptosporidium: impact of malnutrition with preservation of cytokine secretion |
Q35329206 | Iron-regulated lysis of recombinant Escherichia coli in host releases protective antigen and confers biological containment |
Q35689518 | Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis |
Q36970553 | Low-pH rescue of acid-sensitive Salmonella enterica Serovar Typhi Strains by a Rhamnose-regulated arginine decarboxylase system |
Q34560345 | Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity. |
Q34121874 | Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies |
Q43135801 | Multicopy integration of mini-Tn7 transposons into selected chromosomal sites of a Salmonella vaccine strain |
Q36653379 | New technologies in developing recombinant attenuated Salmonella vaccine vectors |
Q41868899 | Novel methods for expression of foreign antigens in live vector vaccines |
Q91689946 | Regulated Delayed Shigella flexneri 2a O-antigen Synthesis in Live Recombinant Salmonella enterica Serovar Typhimurium Induces Comparable Levels of Protective Immune Responses with Constitutive Antigen Synthesis System |
Q27011946 | Salmonella as a vaccine delivery vehicle |
Q36277335 | The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine |
Q33801051 | The delicate balance in genetically engineering live vaccines |
Search more.